Centrum and Tresiba drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Centrum (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Tresiba (insulin degludec). Common drug interactions include feeding disorder among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Centrum and Tresiba. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Centrum?

Centrum has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 34,686 Centrum users. Check the latest studies of Centrum.

What is Tresiba?

Tresiba has active ingredients of insulin degludec. It is often used in type 1 diabetes. eHealthMe is studying from 20,677 Tresiba users. Check the latest studies of Tresiba.



On Jul, 06, 2026

59 people who take Centrum and Tresiba together, and have interactions are studied.

Centrum and Tresiba drug interactions.

What are the common drug interactions of Centrum and Tresiba, by gender? *:

female:

  1. Feeding disorder (when children refuse to eat certain food groups)
  2. Foot fracture
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Hallucination (an experience involving the perception of something not present)
  5. Hand fracture
  6. Injection site bruising
  7. Injection site haemorrhage (bleeding from injection site)
  8. Injection site pain
  9. Intestinal obstruction
  10. Intestinal ulcer

male:

  1. Cardiac failure congestive
  2. Influenza
  3. Myocarditis (inflammation of heart muscle myocardium)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Abdominal pain
  8. Arthralgia (joint pain)
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Asthenia (weakness)

What are the common drug interactions of Centrum and Tresiba, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cystic fibrosis (disease of the secretary glands)
  2. Lung disorder (lung disease)

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiac failure congestive
  2. Influenza
  3. Pain
  4. Bell's palsy (facial paralysis)
  5. Blood glucose increased
  6. Chronic kidney disease
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Normal pressure hydrocephalus (a neurological disorder in which there is too much cerebrospinal fluid in the ventricles of the brain)
  9. Oral candidiasis (fungal infection of mouth)
  10. Renal failure (kidney dysfunction)

60+:

  1. Urinary tract infection
  2. Fall
  3. Renal failure (kidney dysfunction)
  4. Dyspnoea (difficult or laboured respiration)
  5. Lung disorder (lung disease)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Renal infarct (kidney damage due to lack of blood supply)
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Cardiac failure
  10. Chronic kidney disease

What are the existing conditions these people have? *

  1. Diabetes: 12 people, 20.34%
  2. High Blood Pressure: 12 people, 20.34%
  3. Pain: 10 people, 16.95%
  4. High Blood Cholesterol: 9 people, 15.25%
  5. Type 2 Diabetes: 9 people, 15.25%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 13.56%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 10.17%
  8. Blood Pressure Abnormal: 6 people, 10.17%
  9. Chest Pain: 6 people, 10.17%
  10. Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Centrum and Tresiba?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Centrum and Tresiba:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Centrum:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tresiba:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Centrum and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tresiba and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e and insulin degludec (the active ingredients of Centrum and Tresiba, respectively), and Centrum and Tresiba (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: